List of Sarepta Therapeutics patents

Patents where

Current Assignee

Name

Sarepta Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8697858 Antisense antiviral compound and method for treating influenza viral infection	Patent 8697858 was granted and assigned to Sarepta Therapeutics on April, 2014 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	8697858	April 15, 2014
‌ US Patent 9982261 Antisense antiviral compounds and methods for treating a filovirus infection	Patent 9982261 was granted and assigned to Sarepta Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9982261	May 29, 2018
‌ US Patent 8741863 Compound and method for treating myotonic dystrophy	Patent 8741863 was granted and assigned to Sarepta Therapeutics on June, 2014 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	8741863	June 3, 2014
‌ US Patent 9416361 Splice-region antisense composition and method	Patent 9416361 was granted and assigned to Sarepta Therapeutics on August, 2016 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9416361	August 16, 2016
‌ US Patent 10533174 Splice-region antisense composition and method	Patent 10533174 was granted and assigned to Sarepta Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10533174	January 14, 2020
‌ US Patent 10337003 Compositions for treating muscular dystrophy	Patent 10337003 was granted and assigned to Sarepta Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10337003	July 2, 2019
‌ US Patent 11555189 Antisense oligomer compounds		Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11555189	January 17, 2023
‌ US Patent 10066228 Oligonucleotides for treating expanded repeat diseases	Patent 10066228 was granted and assigned to Sarepta Therapeutics on September, 2018 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	10066228	September 4, 2018
‌ US Patent 10364431 Compositions for treating muscular dystrophy	Patent 10364431 was granted and assigned to Sarepta Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10364431	July 30, 2019
‌ US Patent 11472824 Processes for preparing phosphorodiamidate morpholino oligomers		Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11472824	October 18, 2022
‌ US Patent 9434948 Multiple exon skipping compositions for DMD	Patent 9434948 was granted and assigned to Sarepta Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9434948	September 6, 2016
‌ US Patent 11384105 Processes for preparing oligomers	Patent 11384105 was granted and assigned to Sarepta Therapeutics on July, 2022 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11384105	July 12, 2022
‌ US Patent 9506058 Compositions for treating muscular dystrophy	Patent 9506058 was granted and assigned to Sarepta Therapeutics on November, 2016 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	9506058	November 29, 2016
‌ US Patent 9447417 Multiple exon skipping compositions for DMD	Patent 9447417 was granted and assigned to Sarepta Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9447417	September 20, 2016
‌ US Patent 9161948 Peptide oligonucleotide conjugates	Patent 9161948 was granted and assigned to Sarepta Therapeutics on October, 2015 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	9161948	October 20, 2015
‌ US Patent 9862946 Peptide oligonucleotide conjugates	Patent 9862946 was granted and assigned to Sarepta Therapeutics on January, 2018 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9862946	January 9, 2018
‌ US Patent 10905709 Modified antisense oligomers for exon inclusion in spinal muscular atrophy	Patent 10905709 was granted and assigned to Sarepta Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10905709	February 2, 2021
‌ US Patent 11472866 Adeno-associated virus antibodies, fragments thereof and encoding polynucleotides	Patent 11472866 was granted and assigned to Sarepta Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11472866	October 18, 2022
‌ US Patent 9453225 Multiple exon skipping compositions for DMD	Patent 9453225 was granted and assigned to Sarepta Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9453225	September 27, 2016
‌ US Patent 9234198 Multiple exon skipping compositions for DMD	Patent 9234198 was granted and assigned to Sarepta Therapeutics on January, 2016 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9234198	January 12, 2016
‌ US Patent 9447416 Multiple exon skipping compositions for DMD	Patent 9447416 was granted and assigned to Sarepta Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9447416	September 20, 2016
‌ US Patent 11395855 Exon skipping oligomer conjugates for muscular dystrophy		Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11395855	July 26, 2022
‌ US Patent 11642364 Exon skipping oligomer conjugates for muscular dystrophy	Patent 11642364 was granted and assigned to Sarepta Therapeutics on May, 2023 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11642364	May 9, 2023
‌ US Patent 8835402 Compound and method for treating myotonic dystrophy	Patent 8835402 was granted and assigned to Sarepta Therapeutics on September, 2014 by the United States Patent and Trademark Office.	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	8835402	September 16, 2014
‌ US Patent 8895722 Splice-region antisense composition and method	Patent 8895722 was granted and assigned to Sarepta Therapeutics on November, 2014 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	8895722	November 25, 2014

Results per page:

100 results

0 selected

100 results

0 selected